Hidejiro Kawahara Selected Research

Hidejiro Kawahara Research Topics

Disease

17	Colorectal Neoplasms (Colorectal Cancer) 11/2019 - 05/2004
14	Neoplasms (Cancer) 10/2020 - 11/2005
10	Rectal Neoplasms (Rectal Cancer) 06/2019 - 01/2006
5	Neoplasm Metastasis (Metastasis) 01/2021 - 06/2012
3	Constipation 09/2022 - 01/2012
3	Ulcerative Colitis 03/2022 - 10/2017
2	Postoperative Hemorrhage 09/2022 - 03/2009
2	Ileus 01/2021 - 01/2009
2	Colonic Neoplasms (Colon Cancer) 11/2019 - 06/2012
2	Lymphatic Metastasis 06/2019 - 01/2012
2	Circulating Neoplastic Cells 04/2013 - 10/2012
2	Anastomotic Leak 01/2010 - 05/2008
1	Gastric Outlet Obstruction 01/2021
1	Sepsis (Septicemia) 07/2019
1	Rupture 06/2019
1	Abdominal Abscess 06/2019
1	Intestinal Pseudo-Obstruction (Intestinal Pseudoobstruction) 06/2019
1	Body Weight (Weight, Body) 01/2019
1	Sarcoma (Soft Tissue Sarcoma) 01/2018
1	Anus Neoplasms (Anal Cancer) 10/2017
1	Inflammation (Inflammations) 10/2017
1	Wound Infection (Wound Infections) 10/2017
1	Wounds and Injuries (Trauma) 10/2014
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2012
1	Sigmoid Neoplasms 06/2012
1	Crohn Disease (Crohn's Disease) 09/2010
1	Carcinoma (Carcinomatosis) 09/2010
1	Abscess 05/2008
1	Surgical Wound Infection 05/2008
1	Hemorrhage 01/2005

Drug/Important Bio-Agent (IBA)

4	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2014 - 06/2012
4	AntigensIBA 10/2007 - 11/2005
3	Carcinoembryonic AntigenIBA 09/2018 - 11/2005
3	Fluorouracil (Carac)FDA LinkGeneric 06/2012 - 05/2004
3	Thymidine PhosphorylaseIBA 11/2008 - 01/2006
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2018 - 06/2012
2	Capecitabine (Xeloda)FDA Link 01/2014 - 09/2013
2	XELOXIBA 01/2014 - 09/2013
2	EnzymesIBA 05/2013 - 10/2010
2	Leucovorin (Folinic Acid)FDA Link 06/2012 - 05/2004
2	Pharmaceutical PreparationsIBA 01/2012 - 01/2009
2	Indicators and Reagents (Reagents)IBA 09/2010 - 01/2006
2	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 09/2010 - 03/2008
2	Thymidylate SynthaseIBA 09/2010 - 03/2008
2	VaccinesIBA 10/2007 - 01/2007
1	ChromatinIBA 10/2020
1	AlbuminsIBA 01/2019
1	Hemoglobins (Hemoglobin)IBA 01/2019
1	Cholinesterases (Cholinesterase)IBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	Panitumumab (Vectibix)FDA Link 01/2018
1	trifluridine tipiracil drug combinationIBA 01/2018
1	ImmunosorbentsIBA 05/2013
1	Cetuximab (Erbitux)FDA Link 06/2012
1	Bevacizumab (Avastin)FDA Link 06/2012
1	PotassiumIBA 01/2012
1	Oxonic AcidIBA 01/2012
1	TegafurIBA 01/2012
1	gimeracilIBA 01/2012
1	Tumor Biomarkers (Tumor Markers)IBA 10/2010
1	AntibodiesIBA 10/2010
1	Interleukin-12 (IL 12)IBA 10/2007
1	Penicillins (Penicillin)FDA Link 01/2007
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2007
1	PicibanilIBA 01/2007
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2006
1	Neoplasm Antigens (Tumor Antigens)IBA 11/2005
1	Isoantigens (Alloantigen)IBA 11/2005
1	4- chloro- 3',6'- dimethyl- 2,2'- iminodibenzoate (TO 115)IBA 01/2005

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 11/2019 - 05/2004
5	Lymph Node Excision (Lymph Node Dissection) 01/2021 - 01/2007
4	Ileostomy 06/2019 - 05/2008
3	Colectomy 09/2022 - 09/2010
3	Sutures (Suture) 06/2019 - 03/2009
3	Adjuvant Chemotherapy 11/2015 - 01/2012
3	Therapeutics 09/2013 - 06/2012
2	Length of Stay 09/2022 - 05/2008
2	Colonic Pouches (S Pouch) 03/2022 - 10/2017
2	Restorative Proctocolectomy 03/2022 - 01/2019
2	Hepatectomy 09/2018 - 09/2013
1	Decompression 01/2021
1	Gastrectomy 01/2021
1	Operative Surgical Procedures 01/2021
1	Artificial Respiration (Mechanical Ventilation) 07/2019
1	Chemoradiotherapy 06/2019
1	Proctectomy 10/2017
1	Radiotherapy 11/2012
1	Hysterectomy 11/2012
1	Segmental Mastectomy (Lumpectomy) 06/2012
1	Cesarean Section (Caesarean Section) 01/2012
1	Appendectomy 01/2012
1	Catheters 01/2010
1	Immunotherapy 11/2005